Rare Disease & Gene Therapy Digest • July 27, 2026 Rare Disease & Gene Therapy Digest July 27, 2026 AstraZeneca’s rare disease drug Ultomiris missed the primary endpoint… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here